These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38492894)

  • 1. Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2
    Xie Y; Zhou T; Li X; Zhao K; Bai W; Hou X; Liu Z; Ni B; Zhang Z; Yan J; Wang Y; Jiang W; Wang H; Chang A; Gao S; Zhao T; Yang S; Huang C; Liu J; Hao J
    Gastroenterology; 2024 Jul; 167(2):281-297. PubMed ID: 38492894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting both tumour-associated CXCR2
    Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
    Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
    Chao T; Furth EE; Vonderheide RH
    Cancer Immunol Res; 2016 Nov; 4(11):968-982. PubMed ID: 27737879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
    Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
    Bianchi A; De Castro Silva I; Deshpande NU; Singh S; Mehra S; Garrido VT; Guo X; Nivelo LA; Kolonias DS; Saigh SJ; Wieder E; Rafie CI; Dosch AR; Zhou Z; Umland O; Amirian H; Ogobuiro IC; Zhang J; Ban Y; Shiau C; Nagathihalli NS; Montgomery EA; Hwang WL; Brambilla R; Komanduri K; Villarino AV; Toska E; Stanger BZ; Gabrilovich DI; Merchant NB; Datta J
    Cancer Discov; 2023 Jun; 13(6):1428-1453. PubMed ID: 36946782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain-of-function p53
    Siolas D; Vucic E; Kurz E; Hajdu C; Bar-Sagi D
    Cell Rep; 2021 Aug; 36(8):109578. PubMed ID: 34433022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.
    Wallace AE; Sales KJ; Catalano RD; Anderson RA; Williams AR; Wilson MR; Schwarze J; Wang H; Rossi AG; Jabbour HN
    Cancer Res; 2009 Jul; 69(14):5726-33. PubMed ID: 19549892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.
    Jablonska J; Wu CF; Andzinski L; Leschner S; Weiss S
    Int J Cancer; 2014 Mar; 134(6):1346-58. PubMed ID: 24154944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 Inhibits Antitumor Immunity by Targeting m
    Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
    Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
    Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
    Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy.
    Shao S; Delk NA; Jones CN
    Sci Rep; 2024 Jun; 14(1):14142. PubMed ID: 38898176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.
    Chintakuntlawar AV; Chodosh J
    J Interferon Cytokine Res; 2009 Oct; 29(10):657-66. PubMed ID: 19642907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.
    Steele CW; Karim SA; Leach JDG; Bailey P; Upstill-Goddard R; Rishi L; Foth M; Bryson S; McDaid K; Wilson Z; Eberlein C; Candido JB; Clarke M; Nixon C; Connelly J; Jamieson N; Carter CR; Balkwill F; Chang DK; Evans TRJ; Strathdee D; Biankin AV; Nibbs RJB; Barry ST; Sansom OJ; Morton JP
    Cancer Cell; 2016 Jun; 29(6):832-845. PubMed ID: 27265504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
    Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
    Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Zhou T; Liu J; Xie Y; Yuan S; Guo Y; Bai W; Zhao K; Jiang W; Wang H; Wang H; Zhao T; Huang C; Gao S; Wang X; Yang S; Hao J
    Gut; 2022 Feb; 71(2):357-371. PubMed ID: 33674341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
    Pan JJ; Xie SZ; Zheng X; Xu JF; Xu H; Yin RQ; Luo YL; Shen L; Chen ZR; Chen YR; Yu SZ; Lu L; Zhu WW; Lu M; Qin LX
    Cancer Lett; 2024 Jun; 592():216903. PubMed ID: 38670307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice.
    Hoffman MT; Kemp SB; Salas-Escabillas DJ; Zhang Y; Steele NG; The S; Long D; Benitz S; Yan W; Margolskee RF; Bednar F; Pasca di Magliano M; Wen HJ; Crawford HC
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):349-369. PubMed ID: 32882403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.